Skip to main content
Health Care Financing Review logoLink to Health Care Financing Review
. 2006 Spring;27(3):63–82.

Identifying Potentially Preventable Complications Using a Present on Admission Indicator

John S Hughes, Richard F Averill, Norbert I Goldfield, James C Gay, John Muldoon, Elizabeth McCullough, Jean Xiang
PMCID: PMC4194950  PMID: 17290649

Abstract

This article describes the development of Potentially Preventable Complications (PPCs), a new method that uses a present on admission (POA) indicator to identify in-hospital complications among secondary diagnoses that arise after admission. Analyses that used PPCs to obtain risk-adjusted complication rates for California hospitals showed that (1) the POA indicator is essential for identifying complications, (2) frequency of complications varies by reason for admission and severity of illness (SOI), (3) complications are associated with higher hospital charges, longer lengths of stay, and increased mortality, and (4) hospital complication rates tend to be stable over time.

Introduction

The Institute of Medicine's 2000 report on the human and financial costs of medical errors, accelerated efforts to improve patient safety in the U. S. (Kohn, Corrigan, and Donaldson, 2000). Since then, an increasing number of policymakers have advocated not only public reporting of quality measures, but also linking payment to quality measures (Midwest Business Group on Health 2002; Medicare Payment Advisory Commission, 2005; National Committee for Quality Assurance, 2004). Performance-based payment proposals include rewards not only based on processes of care guidelines, but also on outcome measures such as mortality and complication rates. Performance measures are seen as a way to focus quality improvement efforts and to achieve a safer health care system.

In order to determine hospital complication rates, several investigators have created methods using computerized discharge abstract data as an alternative to the time and expense of detailed chart review (Brailer et al., 1996; DesHarnais et al., 1990; Iezzoni et al., 1994; Iezzoni 1992; Romano et al., 2003). The ability to identify complications from discharge abstract diagnoses has been limited, however, because in most of the U.S. it is not possible to distinguish diagnoses that were present at the time of admission from those that arose after admission. As a result, the identification of complications has been limited to secondary diagnoses that are either unlikely to have been present on admission or are complications by definition (e.g., post-operative wound infection). Therefore, complications screening methods have tended to focus on patients that would be unlikely to have had a major complicating problem at the time of admission, such as those undergoing elective surgery. Even with these limits, however, complications screening methods still identify many cases where the condition was preexisting rather than hospital acquired (Lawthers et al., 2000, Naessens and Huschka, 2004).

The lack of a POA indicator also limits the use of risk-adjustment methods for complications screening. Risk of complications varies by the reason for admission, the severity of the underlying illness, and the presence of coexisting diagnoses at the time of admission (Thomas and Brennan, 2000). If present on admission, secondary diagnoses can be used to adjust for a patient's risk of complications; if not present on admission, they could represent complications of care, and should not be used for risk adjustment.

The reason for admission is an important determinant of a patient's risk of complications. Patients treated for medical conditions will be at risk for different complications, and at different rates, than patients admitted for surgery. Among surgical patients, the type of surgery will strongly influence the type and frequency of complications. For example, a patient admitted for coronary bypass grafting will be more likely to develop heart failure than one admitted for a hernia repair. Susceptibility to complications also varies widely among medical patients; a patient admitted with a stroke will be more likely to develop aspiration pneumonia than one admitted with acute urinary retention.

Risk of complications also depends on the severity of the illness that caused the admission, as well as the presence of coexisting illnesses. Patients hospitalized with a more severe form of the underlying illness or with multiple comorbid conditions have a higher risk of complications (Daley, Henderson, and Khuri, 2001; Rosen et al., 1995; Rothschild, Bates, and Leape, 2000). Fair comparisons of complication rates across hospitals require the use of risk-adjustment methods that account for each of these factors.

A POA indicator is currently required on all hospital discharge abstracts by New York and California. It has been proposed as an additional data element on the Uniform Billing form commonly referred to as the UB-04, and has been mandated by the Deficit Reduction Act of 2005 to be used on all bills submitted to Medicare beginning in October 2007. This article describes a new method of reporting risk-adjusted in-hospital complication rates using discharge abstract data and a present on admission indicator for secondary diagnoses. The POA indicator serves two purposes: (1) to create a method for identifying potentially preventable complications from among diagnoses not present on admission, and (2) to allow only those diagnoses designated as present on admission to be used for assessing the risk of incurring complications.

PPC System Methods

Overview

In developing the PPC System it was first necessary to identify the subset of diagnoses that, if not present on admission, would represent potentially preventable complications, and assemble them into groups containing similar diagnoses. The next step was to determine the types of patients for whom each group of complications was potentially preventable. The final step was to adjust for susceptibility to complications based on the reason for admission, SOI, and comorbid conditions. We could then calculate and compare actual and expected risk-adjusted complication rates for individual hospitals using norms derived from statewide average complication rates. This study in particular examines the effect of the reason for admission and admission SOI on patients' susceptibility to potentially preventable complications, and the effect of complications on costs and mortality.

Identifying and Classifying Diagnosis Codes

A core group of three physicians (two general internists and one pediatrician) supplemented by surgical, medical, obstetric, and pediatric specialists as needed, was responsible for creating a list of potentially preventable complications. The core panel first reviewed the existing literature and incorporated most of the diagnosis codes used in the Complications Screening Program (CSP) developed by Iezzoni and colleagues (1994; 1992) and the Patient Safety Indicators (PSI) from the Agency for Healthcare Research and Quality (2005). The physician panel then conducted its own review of all International Classification of Diseases Ninth Revision-Clinical Modification (ICD-9-CM) diagnosis codes to identify additional potentially preventable complications (Centers for Disease Control and Prevention, 2006).

We defined in-hospital complications as harmful events (e.g., accidental laceration during a procedure, improper administration of medication) or negative outcomes (e.g., hospital-acquired pneumonia, Clostridium Difficile Colitis) that may result from the processes of care and treatment rather than from natural progression of the underlying illness.

Complications do not necessarily represent medical errors, since they are not always preventable even with optimal care. In deciding which complications to classify as potentially preventable, the physician panel developed the following conceptual guide: If a hospital or other health care facility were to have a statistically significant, higher rate of a particular complication than comparable hospitals, reasonable clinicians would suggest further investigation for possible problems with quality of care.

The following specific criteria also provided guidance in choosing PPC diagnoses. In order to be considered a PPC diagnosis, the secondary diagnosis should:

  • Not be redundant with the diagnosis that was the reason for hospital admission (e.g., a diagnosis of stroke in a patient admitted with intracranial hemorrhage).

  • Not be an inevitable, natural, or expected consequence or manifestation of the reason for hospital admission (e.g., stroke in a patient admitted with a brain malignancy).

  • Be expected to have a significant impact on short- or long-term debility, mortality, patient suffering, or resource use.

  • Have a relatively narrow spectrum of manifestations, meaning that the impact of the diagnosis on the clinical course or on resource use must not be significant for some patients, but trivial for others (e.g., iron deficiency anemia, atelectasis).

Of the 12,988 ICD-9-CM diagnosis codes, we identified 1,357 codes as PPC diagnoses. We then assigned each PPC diagnosis to one of 66 mutually exclusive complication groups based on similarities in clinical presentation and clinical impact (Table 1). The number of diagnosis codes in a complication group ranged from 1 (Clostridium Difficile Colitis) to 215 (Poisoning Due to Drugs and Biological Substances). Table 2 contains examples of three complication groups.

Table 1. List of Potentially Preventable Complications Groups (PPCs).

Group Description
1* Stroke & Intracranial Hemorrhage
2* Extreme CNS Complications
3* Acute Lung Edema & Respiratory Failure
4* Pneumonia, Lung Infection
5* Aspiration Pneumonia
6* Pulmonary Embolism
7 Complications of Thoracic Surgery & Other Pulmonary Complications
8* Shock
9* Congestive Heart Failure
10* Acute Myocardial Infarct
11 Cardiac Arrythmias & Conduction Disturbances
12 Other Cardiac Complications
13* Ventricular Fibrillation/Cardiac Arrest
14 Hypotension
15* Peripheral Vascular Complications Except Venous Thrombosis
16 Venous Thrombosis
17 Major GI Complications without Significant Bleeding
18* Major GI Complications with Significant Bleeding
19* Major Liver Complications
20 Other GI Complications without Report Of Significant Bleeding
21* Other GI Complications with Report Of Significant Bleeding
22 Clostridium Difficile Colitis
23 Urinary Tract Infection
24 Complications of GU Surgery & Other GU Complications Except UTI
25 Renal Failure without Dialysis
26* Renal Failure with Dialysis
27 Diabetic Ketoacidosis & Coma
28 Endocrine & Metabolic Complications except Diabetic Ketoacidosis/Coma
29 Post-Hemorrhagic & Other Acute Anemia without Transfusion
30* Post-Hemorrhagic & Other Acute Anemia with Transfusion
31 Limb Fractures
32 Poisonings Of Drugs & Biological Substances
33 Anesthesia Poisonings & Adverse Effects
34 Abnormal Reactions
35* Decubitus Ulcer
36 Transfusion Incompatibility Reaction
37 Moderate Infectious Complications
38* Septicemia & Severe Infection
39 Adverse Effects Of Drugs, Transfusions & Biological Substances
40 Acute Mental State Changes
41 Post-Op Wound Infection & Deep Wound Disruption without Procedure
42* Post-Op Wound Infection & Deep Wound Disruption with Procedure
43* Reopening Or Revision Of Surgical Site
44 Post-Op Hemorrhage & Hematoma without Hemorrhage Control Or I&D Procedure
45* Post-Op Hemorrhage & Hematoma with Hemorrhage Control Or I&D Procedure
46 Accidental Puncture/Laceration During O.R. Procedure
47 Non-O.R. Procedure Laceration
48 Other Surgical Complication - Mod
49* Post-Op Foreign Body & Inappropriate Operation
50 Post-Op Substance Reaction & Non-O.R. Procedure for Foreign Body
51* Other Major Complications Of Medical Care
52 Other Complications Of Medical Care
53 Iatrogenic Pneumothrax
54* Malfunction Device, Prosthesis, Graft
55 GI Ostomy Complications
56* Infection/Inflammation & Other Complication Of Device/Graft ex Vascular Infection
57 Complications Of Peripheral Intravenous Catheters
58* Complications Of Central Venous & Other Vascular Catheters & Devices
59 Obstetrical Hemorrhage without Transfusion
60* Obstetrical Hemorrhage wtih Transfusion
61 Obstetric 3rd&4th Degree Lacerations & Other Trauma
62 Medical & Anesthesia Obstetric Complications
63* Major Obstetrical Complications
64 Other Complications Of Delivery
65 Delivery with Placental Complications
66* Post-Operative Respiratory Failure with Tracheostomy
*

Major PPCs.

NOTE: The PPC System identifies in-hospital complications among secondary diagnoses not designated as present on admission (POA).

SOURCES: Hughes, J.S., Averill, R.F., Goldfield, N.I., Gay, J.C., Muldoon, J., McCullough, E., Xiang, J., 2005.

Table 2. Examples of the Diagnosis and Procedure Codes for Three Complication Groups in the Potentially Preventable Complications (PPCs) System.

ICD-9-CM Code Description
PPC 01 Stroke and Intracranial Hemorrhage
Any one of the following diagnosis codes:
430 Subarachnoid Hemorrhage
431 Intracerebral Hemorrhage
4320 Nontraumatic Extradural Hemmorhage
4321 Subdural Hemorrhage
4329 Intracranial Hemorrhage NOS
43301 Occlusion of Basilar Artery with Infarction
43311 Occlusion of Carotid Artery with Infarction
43321 Occlusion of Vertebral Artery with Infarction
43331 Occlusion of Multiple and Bilateral Arteries with Infarction
43381 Occlusion of Other Specified Precerebral Artery with Infarction
43391 Occlusion of Unspecified Precerebral Artery with Infarction
43401 Cerebral Thrombosis with Infarction
43411 Cerebral Embolism with Infarction
43491 Cerebral Artery Occlusion, Unspecified, with Infarction
436 Acute Cerebrovascular Disease
99702 Iatrogenic Cerebrovascular Infarction or Hemorrhage
PPC 03 Acute Lung Edema and Respiratory Failure
Any one of the following diagnosis codes:
5184 Acute Lung Edema NOS
5185 Post Traumatic Pulmonary Insufficiency
51881 Acute Respiratory Failure
51884 Acute & Chronic Respiratory Failure
7991 Respiratory Arrest
Or one of the Following Procedure Codes:
(Occurring > 2 Days after Admission or > 1 Day after a Significant Surgical Procedure)
9604 Insertion Of Endotracheal Tube
9670 Continuous Mechanical Ventilation for Unspecified Duration
9671 Continuous Mechanical Ventilation for Less than 96 Hours
Or the Following Procedure Code:
(Occurring > 2 Days after Admission (for Non-Surgical APR DRGs) or > 0 day post first significant surgery)
9672 Continuous Mechanical Ventilation for at least 96 Hours
PPC 05 Aspiration Pneumonia
Any one of the following diagnosis codes:
5070 Pneumonitis Due to Inhalation of Food or Vomitus
5071 Pneumonitis Due to Inhalation of Oils or Essences
5078 Pneumonitis Due to Other Solids or Liquids

NOTES: Table shows three complication groups of the 66 groups in the PPC system. APR DRGs are All-Patient Refined Diagnosis-Related Groups.

SOURCES: Hughes, J.S., Averill, R.F., Goldfield, N.I., Gay, J.C., Muldoon, J., McCullough, E., Xiang, J., 2005.

Use of Procedure Codes

In addition to diagnosis codes, we used procedure codes to create some of the complication groups. In some cases, the procedure by itself could assign a patient to a complication group. For example, in addition to the five diagnosis codes shown in the second example in Table 2, the procedure codes for endotracheal intubation or mechanical ventilation, if they met the appropriate timing criteria, could also generate the complication groups Acute Pulmonary Edema and Respiratory Failure. In other cases, the procedure code was combined with a diagnosis code to differentiate complication groups with greater clinical impact. For example, a patient with a secondary diagnosis of acute post-hemorrhagic anemia, not present on admission, would be assigned to a PPC named Hemorrhage or Anemia without Transfusion. The same diagnosis accompanied by a code for blood transfusion (at least 2 days after admission) would assign the patient to a different complication group, hemorrhage or anemia with transfusion.

Exclusions by Reason for Admission

A PPC diagnosis may be preventable for some types of patients, but not for others. Therefore the physician panel created clinical exclusions for each complication group. Some complication groups apply to only certain types of patients; for example post-operative complications occur only in surgical patients, and obstetric complications occur only in females who deliver after admission. The panel created a series of more specific clinical exclusions, most commonly dealing with possible complication diagnoses that were redundant codes or a natural consequence of one of the diagnoses present on admission, and therefore unpreventable. For example, the complication group aspiration pneumonia was not considered preventable for patients admitted with seizures, head trauma, respiratory failure requiring ventilator support, or septicemia. Table 3 contains exclusion criteria for each of the complication groups shown in Table 2.

Table 3. Examples of Exclusion Criteria for Three Complication Groups in the Potentially Preventable Complications (PPCs) System.

Group Description
PPC 01 Stroke and Intracranial Hemorrhage
Will Not Count as a Complication for Patients Admitted with Any of the Following Conditions:
  • Intracranial Hemorrhage

  • CVA, Cerebral Infarction

  • Cerebral Artery Dissection

  • Severe Non-Traumatic Brain Injury

  • Brain Contusion/Laceration and Complicated Skull Fracture

And Will Not Apply to Patients with Ventilator Support Greater than 96 Hours
PPC 03 Acute Lung Edema and Respiratory Failure
Will Not Count as a Complication for Patients Admitted with:
  • Pulmonary Edema and Respiratory Failure

  • Septicemia and Disseminated Infections

And Will Not Apply to:
  • Patients with Ventilator Support Greater than 96 Hours

  • Patients with Tracheostomy and Prolonged Mechanical Ventilation

And Will Not Count as Complications for Surgical and Obstetric Patients Admitted with:
  • Intracranial Hemorrhage

  • Non-Traumatic Stupor and Coma

  • Pulmonary Embolism

  • Acute Myocardial Infarction

  • Acute Heart Failure

PPC 05 Aspiration Pneumonia
Will Not Count as a Complication for Patients Admitted with:
  • Seizures

  • Brain Contusions, Lacerations and Complicated Skull Fractures

  • Uncomplicated Closed Skull Fractures with Concussion

  • Hematologic Malignancies and Immunocompromised States

  • Septicemia and Disseminated Infections

And Will Not Apply to Patients with Ventilator Support Greater than 96 Hours

NOTE: Table shows three complication groups of the 66 groups in the PPC system.

SOURCES: Hughes, J.S., Averill, R.F., Goldfield, N.I., Gay, J.C., Muldoon, J., McCullough, E., Xiang, J., 2005.

The application of the POA logic and exclusion criteria makes a complication group potentially preventable, and the result is called a PPC Group. The PPC Groups are the final product of the PPC system logic. Hereafter the PPC Groups will be referred to as PPCs.

The panel also created global exclusions for patients with certain severe or catastrophic illnesses that were particularly susceptible to a range of complications, including those with trauma, HIV, and major or metastatic malignancies. These analyses also excluded newborns, which will be addressed by future versions of the PPC System. Details of these global exclusions are available on request from the authors.

Patients that were not globally excluded and had no specific clinical exclusions were considered at risk for the PPC, and therefore were included in the PPC rate calculation.

Differences from Previous Methods

The PPC System incorporates the great majority of the diagnosis codes used in both the CSP and PSI. PPCs use 502 of the 532 diagnosis codes (94 percent) and all 26 procedure codes used in CSP, and use 116 of 123 possible diagnosis codes (94 percent) and all 29 procedure codes used by the PSI. PPCs omit 1 complication of anesthesia code used by PSI, and 6 codes relating to obstetric lacerations (out of a total of 15) that our consultants thought would have only a minor impact on patient care. We added 524 diagnosis codes that were present in neither system. The most important difference with CSP and PSI was that the POA indicator allowed the PPCs to apply the complications to a larger group of patients—mainly to patients admitted with medical diagnoses. Most of the complications detected by both CSP and PSI occur in post-operative patients. Details of differences with CSP and PSI are available on request from the authors.

Use of APR DRGs for Risk Adjustment

We used All-Patient Refined Diagnosis Related Groups (APR DRGs) version 20 to classify patients according to their reason for admission and SOI at admission. (Averill et al., 2002) APR DRGs use data from computerized discharge abstracts to assign patients to one of 314 base APR DRGs that are determined either by the principal diagnosis, or for surgical patients, the most important surgical procedure performed in an operating room. Each base APR DRG is then divided into four risk subclasses, determined primarily by secondary diagnoses that reflect both comorbid illnesses and severity of the principal diagnosis, creating the final set of 1,256 groups. The risk subclasses take two different forms: (1) risk of mortality, and (2) SOI. SOI was used to stratify the risk of complications in all of the analyses that follow, except that risk of mortality was used in examining the association of complications with increased mortality. The combination of the base APR DRG and the risk subclass is referred to as the APR DRG. In ordinary use, APR DRGs use all diagnoses from the hospitalization, whether present on admission or not. For risk adjustment of PPC rates in the analyses that follow, however, we used an admission APR DRG that is based on the principal diagnosis from the discharge abstract, but excludes all secondary diagnoses that are not present on admission. Thus, complications and other conditions that arise during the hospitalization are not used for risk adjustment.

Analysis

Data Sources

We analyzed discharge abstract data for 5.15 million discharges from all California hospitals for 1999 and 2000. A total of 520,885 discharges from 99 hospitals that had not recorded the present on admission indicator accurately or consistently were eliminated (screening criteria available on request from the authors). These hospitals tended to be smaller, with an average of 5,304 discharges in the 2-year period compared to an average of 15,646 discharges for the included hospitals, but had similar distributions of age and sex. Another 16,501 discharges from 40 hospitals with fewer than 1,000 discharges and 5 hospitals with a death rate over 15 percent (compared to an average of 2.3 percent for included hospitals) were eliminated out of concern that they would not be representative of acute care hospitals. Thus, we were left with a total of 294 hospitals and 4.62 million discharges. From the eligible hospitals we then excluded 665,782 patients with charges less than $200 or greater than $2 million, or who had lengths of stay (LOS) recorded as zero. We excluded 314,881 patients with certain severe or catastrophic illnesses that were particularly susceptible to a range of complications, including those with trauma, HIV, and major or metastatic malignancies (global exclusions). We also excluded 602,114 newborns from these analyses.

Identifying Patients

This study focused on a subset of 29 major PPCs (Table 1). The major PPCs were selected by consensus of the physician panel as those most likely to have a consistent and significant impact on a patient's clinical course. The ICD-9-CM (Centers for Disease Control and Prevention, 2006) diagnosis and procedure codes that comprise each of the major PPCs are available on request from the author.

We calculated the total number of California patients who had each one of the major PPCs, as well as all patients who had any one of the major PPCs. In order to gauge the impact of the POA indicator, we also identified the number of patients with a PPC secondary diagnosis code that was present on admission, and therefore not counted as a PPC.

Calculating Observed and Expected Rates

We calculated a statewide PPC norm—the average rate for each PPC for each admission APR DRG across all patients who were at risk for the PPC—using data only from those hospitals that passed the POA coding quality screens. Then, using indirect standardization, for each hospital we calculated the expected number of patients for each PPC by multiplying the statewide average rate for each PPC/APR DRG combination by the number of patients in the hospital in each admission APR DRG. The expected number of patients with a PPC in each admission APR DRG summed across all APR DRGs is the hospital's overall expected number of patients with that PPC. In the same manner, we calculated expected rates for combinations of PPCs, and for all patients with any one of the major PPCs noted in Table 1. Any patient with more than one major PPC was only counted once when calculating rates for combinations of PPCs. We calculated differences in actual minus expected rates for individual PPCs and combinations of PPCs, for individual hospitals and for all hospitals in the State. We determined statistical significance using the Cochrane-Mantel-Haenzel (CMH) test (Agresti, 1990).

Evaluating the Impact

In order to examine the impact of the occurrence of a PPC on hospital outcomes, we computed the statewide average charges, LOS, and death rates for each admission APR DRG. Then, using the statewide averages for each admission APR DRG, we computed the expected average charges, LOS and death rates by means of indirect rate standardization for patients with specific PPCs, and for all patients with any of the major PPCs. We then calculated the actual average charges, LOS, and death rates for the same sets of patients, and determined the ratio of actual values to expected values. We determined statistical significance using the CMH test for differences in actual and expected death rates, and Student's t-test for average LOS and charge differences.

Evaluating Stability of Rates Over Time

We calculated actual minus expected rates of patients with any major PPC for the first 6 months of 1999 and the first 6 months of 2000 for all eligible California hospitals. We examined the stability of the actual minus expected rate differences for all hospitals that had a statically significant difference in 1999, 2000, or in both years. We calculated an R2 value for the correlation of actual minus expected differences in the 2 years.

Results

Table 4 contains, for each of the major PPCs, the number of California patients at risk, the total number of patients with a PPC diagnosis, whether present on admission or not, the number of patients excluded because the PPC diagnosis was POA, and the number of patients with a PPC diagnosis not POA, but excluded by a clinical exclusion rule. Table 4 also shows the number of patients with a true PPC and the positive predictive value, calculated as the proportion of true PPCs (not POA and without a clinical exclusion) among all patients with a PPC diagnosis.

Table 4. Major Potentially Preventable Complication (PPC) Groups and Their Occurrence Among California Hospitalizations: 1999-2000.

Major PPC Group (1) (2) (3) (4) (5) PPC Rate per 1,000*** PPV
Patients at Risk All Patients with any PPC Diagnosis** PPC Diagnoses Excluded Because POA PPC Diagnoses with Clinical Exclusions PPC Not POA, Not Excluded - Equals True PPC*
Major Cardiovascular and Pulmonary PPCs
1 Stroke & Intracranial Hemorrhage 2,969,740 15,743 9,797 414 5,532 1.86 0.35
2 Extreme CNS Complications 2,855,451 17,414 14,657 949 1,808 0.63 0.10
3 Acute Lung Edema & Respiratory Failure 2,919,995 135,341 110,404 3,745 21,192 7.26 0.16
4 Pneumonia, Lung Infection 2,704,448 87,366 71,777 3,391 12,198 4.51 0.14
5 Aspiration Pneumonia 2,865,642 20,344 12,033 1,536 6,775 2.36 0.33
6 Pulmonary Embolism 3,022,644 4,443 2,957 1 1,485 0.49 0.33
8 Shock 2,971,169 20,181 15,111 932 4,138 1.39 0.21
9 Congestive Heart Failure 2,686,676 209,524 197,815 890 10,819 4.03 0.05
10 Acute Myocardial Infarct 2,956,739 18,799 12,299 124 6,376 2.16 0.34
13 Ventricular Fibrillation/Cardiac Arrest 3,031,554 27,167 16,103 0 11,064 3.65 0.41
15 Peripheral Vascular Complications Except Venous Thrombosis 3,018,827 20,810 19,379 139 1,292 0.43 0.06
At Least One Major Cardiovascular or Pulmonary PPC 3,031,554 59,850 19.74
Other Major Medical PPCs
18 Major Gastrointestinal Complications with Transfusion 2,614,013 19,552 18,065 190 1,297 0.5 0.07
19 Major Liver Complications 2,994,021 11,594 10,414 456 724 0.24 0.06
21 Other GI Complications with Transfusion Or Post-Hemorrhagic Anemia 2,622,763 7,675 6,447 570 658 0.25 0.09
26 Renal Failure with Dialysis 2,956,451 8,180 6,222 480 1,478 0.5 0.18
30 Post-Hemorrhagic & Other Acute Anemia with Transfusion 1,957,938 36,005 34,066 860 1,079 0.55 0.03
35 Decubitus Ulcer 2,995,583 38,272 35,686 7 2,579 0.86 0.07
38 Septicemia & Severe Infection 2,938,030 60,168 50,132 1,167 8,869 3.02 0.15
51 Other Major Complications Of Medical Care 3,014,401 27,255 22,388 75 4,792 1.59 0.18
At Least One Other Major Medical PPC 3,031,554 19,416 6.4
Major Peri-Operative PPCs
42 Post-Op Wound Infection & Deep Wound Disruption with Procedure 1,083,363 1,634 920 39 675 0.62 0.41
43 Reopening Or Revision Of Surgical Site 1,098,260 14,163 12,917 0 1,246 1.13 0.09
45 Post-Op Hemorrhage with Hemorrhage Control or I&D Procedure 1,098,260 4,381 2,004 23 2,354 2.14 0.54
49 Post-Op Foreign Body & Inappropriate Operation 1,098,260 291 109 9 173 0.16 0.59
66 Post-Op Respiratory Failure with Tracheostomy 2,332,281 1,558 1,215 0 343 0.15 0.22
At Least One Major Peri-Operative PPC 2,595,252 4,732 1.82
Major Complications of Devices, Grafts, Etc.
54 Malfunction Device, Prosthesis, Graft 2,967,872 8,425 6,002 175 2,248 0.76 0.27
56 Infection, Inflammation & Other Complications of Devices & Grafts 2,967,872 9,365 6,529 106 2,730 0.92 0.29
58 Complications Of Central Venous & Other Vascular Catheters & Devices 2,986,171 14,164 8,340 388 5,436 1.82 0.38
At Least One Major Complication Of Devices, Grafts, Etc. 2,986,171 10,136 3.39
Major Obstetrical Complications
60 Obstetrical Hemorrhage with Transfusion 618,708 1,187 159 121 907 1.47 0.76
63 Major Obstetrical Complications 626,438 3,750 310 12 3,428 5.47 0.91
At Least One Major Obstetrical Complication 626,438 4,275 6.82
At Least One Major PPC of any kind 3,031,554 579,424 487,826 7,831 83,767 27.63 0.14
*

Includes only patients with PPC diagnosis codes not present on admission and without clinical exclusions.

**

Includes all PPC diagnosis codes, both present on admission as well as not present on admission and with clinical exclusions (equals the sum of columns 3, 4, and 5).

***

PPC Rate per 1,000 = (column 5 divided by column 1) × 1,000.

NOTES: Numbers in columns do not sum to numbers in subtotal and total rows due to patients with multiple PPCs. POA is present on admission. PPV is positive predictive value (equals column 5 divided by column 2).

SOURCE: Hospital data from California Office of Statewide Health Planning and Development.

As shown in Table 4, there is considerable variation in the occurrence of PPCs, ranging from a low of 0.15 per 1,000 for Post-Operative Respiratory Failure with Tracheostomy to a high of 7.26 per 1,000 for Acute Lung Edema and Respiratory Failure. The overall rate for patients with at least one major PPC is 27.6 per 1,000.

The POA indicator is more important for determining some PPCs than others. For most of the PPCs, the majority of the PPC diagnosis codes were present on admission, as reflected in the low positive predictive values. For those PPCs, screening for complications without the POA indicator would be impractical. For both of the Major Obstetrical PPCs and three of the Major Post-Operative PPCs, however, the number of false positives would have been much lower. The POA indicator is therefore of less value for these PPCs.

The effect of the POA indicator and the exclusion criteria on the number of patients with at least one major PPC is demonstrated in Table 4. Almost 580,000 of the California hospital discharges had at least one secondary diagnosis belonging to a major PPC, but 487,826 were not considered to have a PPC because the PPC diagnosis was present on admission. Another 7,831 were not considered to have a PPC because of clinical exclusions.

Table 5 presents the number and rate of patients per 1,000 who incurred at least one major PPC for a selected group of 20 admission base APR DRGs, sorted by SOI subclass (the APR DRGs severity subclasses were assigned using only secondary diagnoses present on admission). It shows that the rate of major complications varies not only by the reason for admission (categorized by base APR DRG), but also by the admission SOI. The monotonic increases in major PPC rates with increasing admission SOI are representative of all but a few combinations of base APR DRGs and individual PPCs or groups of PPCs. Across all reasons for admission, patients with greater SOI on admission were more susceptible to complications.

Table 5. Percent of Patients with at Least One Major Potentially Preventable Complications Group (PPC) in Selected All-Patient Refined Diagnosis-Related Groups (APR DRGs).

APR DRG Description Admission Severity of Illness (SOI) Level Total

SOI 1 SOI 2 SOI 3 SOI 4
Surgical APR DRGs
Craniotomy except for Trauma PPCs 264 553 663 150 1,630
At Risk 4,339 3,642 2,313 533 10,827
Percent 6.1 15.2 28.7 28.1 15.1
Extracranial Vascular Procedures PPCs 238 297 161 6 702
At Risk 9,850 4,525 822 27 15,224
Percent 2.4 6.6 19.6 22.2 4.6
Coronary Artery Bypass Graft with Catheterization PPCs 336 1,998 1,433 99 3,866
At Risk 3,430 13,260 4,946 348 21,984
Percent 9.8 15.1 29.0 28.5 17.6
Percutaneous Cardiovascular Procedures with Acute Ml PPCs 361 550 335 105 1,351
At Risk 27,295 19,407 4,366 517 51,585
Percent 1.3 2.8 7.7 20.3 2.6
Major Large & Small Bowel Procedures PPCs 320 1,156 1,416 353 3,245
At Risk 8,617 11,017 5,187 894 25,715
Percent 3.7 10.5 27.3 39.5 12.6
Appendectomy PPCs 99 292 70 9 470
At Risk 24,599 13,122 700 47 38,468
Percent 0.4 2.2 10.0 19.2 1.2
Laparoscopic Cholecystectomy PPCs 200 350 245 21 816
At Risk 20,928 12,065 3,057 138 36,188
Percent 1.0 2.9 8.0 15.2 2.3
Hip Joint Replacement PPCs 184 775 654 32 1,645
At Risk 3,506 18,675 10,357 119 32,657
Percent 5.3 4.2 6.3 26.9 5.0
Intervertebral Disc Excision PPCs 89 135 38 1 263
At Risk 22,454 6,073 436 9 28,972
Percent 0.4 2.2 8.7 11.1 0.9
Uterine & Adnexal Procedures Except for Leiomyoma Excision PPCs 263 138 53 4 458
At Risk 34,974 6,828 482 20 42,304
Percent 0.8 2.0 11.0 20.0 1.1
Medical APR DRGs
Cerebrovascular Accidents PPCs 34 590 813 245 1,682
At Risk 4,056 21,231 8,307 1,192 34,786
Percent 0.8 2.8 9.8 20.6 4.8
Major Pneumonia PPCs 41 400 826 729 1,996
At Risk 2,803 11,786 14,329 4,852 33,770
Percent 1.5 3.4 5.8 15.0 5.9
Other Pneumonia PPCs 101 891 1,027 807 2,826
At Risk 24,694 57,313 28,300 3,892 114,199
Percent 0.4 1.6 3.6 20.7 2.5
COPD PPCs 144 432 400 400 1,376
At Risk 20,224 27,677 10,845 2,211 60,957
Percent 0.7 1.6 3.7 18.1 2.3
Acute Ml PPCs 155 976 873 420 2,424
At Risk 6,925 20,510 8,959 2,530 38,924
Percent 2.2 4.8 9.7 16.6 6.2
Congestive Heart Failure PPCs 177 1,366 1,137 369 3,049
At Risk 18,151 59,203 18,390 2,195 97,939
Percent 1.0 2.3 6.2 16.8 3.1
Peptic Disease & Gastritis PPCs 45 274 325 63 707
At Risk 10,099 14,467 6,229 393 31,188
Percent 0.5 1.9 5.2 16.0 2.3
Cellulitis PPCs 24 152 123 23 322
At Risk 15,395 16,089 4,275 187 35,946
Percent 0.2 0.9 2.9 12.3 0.9
Urinary Tract Infection PPCs 35 299 382 61 777
At Risk 10,759 21,556 10,416 655 43,386
Percent 0.3 1.4 3.7 9.3 1.8
Septicemia PPCs 6 288 669 321 1,284
At Risk 1,878 11,064 11,329 2,842 27,113
Percent 0.3 2.6 5.9 11.3 4.7

SOURCE: Hospital data from California Office of Statewide Health Planning and Development.

Table 6 shows the impact of several individual PPCs on death rates, LOS, and charges. In this table, the actual average charges, LOS, and death rates for patients with each PPC are compared to their expected values, which were derived by indirect standardization from the statewide APR DRG averages. The presence of a major PPC is associated with large increases in charges, LOS, and deaths over what would have been expected based on SOI at admission. For example, patients with a PPC of Acute Lung Edema and Respiratory Failure had death rates that were five times higher than expected, and mean LOS and charges twice as high as expected. Although they showed a very strong association with complications, these data cannot be assumed to represent the impact of medical errors on costs, deaths, and LOS. This analysis could not identify the number of true medical errors because, although it identified the number of complications that were potentially preventable, it could not determine how many of those complications were actually preventable.

Table 6. Actual and Expected Death Rate, Length of Stay (LOS), and Charges for Patients With Selected Potentially Preventable Complications Groups (PPCs).

PPC Title PPC Rate Deaths* Mean Length of Stay** Mean Charges**




At Risk PPC/1,000 Actual/1,000 Expected/1,000 Actual/Expect Actual (Days) Expected (Days) Actual/Expect Actual Dollars Expected Dollars Actual/Expect
Stroke & Intracranial Hemorrhage 2,969,740 1.86 0.53 0.13 4.15 15.3 8.2 1.86 114,337 61,158 1.87
Acute Lung Edema & Resp. Failure 2,919,995 7.26 2.74 0.52 5.24 18.1 9.2 1.97 143,872 62,436 2.30
Pneumonia, Lung Infection 2,704,448 4.51 0.75 0.23 3.22 17.9 7.7 2.33 125,302 50,749 2.47
Aspiration Pneumonia 2,865,642 2.36 0.64 0.20 3.27 18.8 8.1 2.32 128,798 50,145 2.57
Pulmonary Embolism 3,022,644 0.49 0.13 0.03 4.90 16.9 7.9 2.15 113,503 51,345 2.21
Congestive Heart Failure 2,686,676 4.03 0.69 0.25 2.71 14.1 7.8 1.81 98,507 53,084 1.86
Acute Myocardial Infarct 2,956,739 2.16 0.62 0.18 3.56 12.6 8.2 1.54 97,917 54,080 1.81
Major GI Complications with Transfusion 2,614,013 0.50 0.14 0.05 2.69 20.3 10.0 2.02 134,883 61,966 2.18
Major Liver Complications 2,994,021 0.24 0.13 0.03 5.14 21.0 10.3 2.04 179,045 70,323 2.55
Renal Failure with Dialysis 2,956,451 0.50 0.28 0.05 5.11 28.5 11.5 2.47 257,594 88,991 2.89
Decubitus Ulcer 2,995,583 0.86 0.17 0.09 1.76 27.9 10.7 2.60 191,603 68,583 2.79
Septicemia & Severe Infection 2,938,030 3.02 1.12 0.29 3.89 25.3 10.6 2.38 189,563 69,497 2.73
Reopening Surgical Site 1,098,260 1.13 0.18 0.08 2.37 18.5 10.3 1.80 149,176 76,704 1.94
Post-Op Hemorrhage with procedure 1,098,260 2.14 0.23 0.08 2.75 13.9 8.5 1.63 139,739 79,957 1.75
All patients with At Least One Major PPCG1 3,031,554 27.63 6.64 2.59 2.56 14.2 8.3 1.71 98,515 55,166 1.79
1

Includes all 29 major PPCs.

*

All differences statistically significant by Cochrane-Mantel-Haenzel (CMH) test at p< 0.01.

**

All differences statistically significant by t-test at p< 0.01.

NOTES: Expected deaths: calculated based on All-Patient Refined Diagnosis Related Group (APR DRG) risk of mortality at admission, using statewide California data for all patients at risk for each PPC. Expected mean LOS and mean charges: calculated based on APR DRG severity of illness at admission, using statewide California data for all patients at risk for each PPC.

SOURCE: Hospital data from California Office of Statewide Health Planning and Development.

Calculation of the difference in the actual minus expected rate of major PPCs for each of the California hospitals yielded a range from -2.48 per 1,000 (better than expected) to 2.79 per 1,000 (worse than expected). Sixty hospitals were classified as having PPC rates significantly lower than expected at a p value of <0.05, and 45 hospitals were classified as having significantly higher PPC rates than expected for the 2-year period.

Stability of Hospital Performance Over Time

Figure 1 plots the actual minus expected major PPCs rate for the first 6 months of 1999 and the first 6 months of 2000 for each of the 179 hospitals that had a statistically significant difference in either of those years (97 of the 179 hospitals had a statistically significant difference in both years). It shows that hospitals that performed worse than expected in one year tended to perform worse than expected in both years, and conversely, those that performed better than expected in one year tended to do so in both years. The R2 value was 0.55 for the correlation between the 2 years.

Figure 1. Correlation of the Difference Between Actual and Expected Hospital Major Potentially Preventable Complication (PPC) Rates per 1,000 Patients: 1999 and 2000.

Figure 1

Discussion

This article describes the development of a new method for evaluating in-hospital complication rates, the first to use the POA indicator applied to statewide data. The PPC method builds on existing complication screening methods, substantially expanding the number of diagnoses that can be considered complications, as well as expanding the number of patients for whom the occurrence of complications can be assessed. These analyses confirm the value of the POA indicator for identifying complications, particularly for those that are neither obstetric nor specific postoperative complications.

These analyses also demonstrate that the reason for admission, comorbid conditions, and admission SOI—measured here by APR DRGs—have a dramatic effect on the risk of complications. The findings emphasize that any comparisons of hospital complication rates, if they are to be fair, require not only the POA indicator to identify complications, but also the availability of adequate risk-adjustment methods. The PPC System provides a built-in risk-adjustment method with APR DRGs assigned using only diagnoses present on admission. PSIs use age, sex, and an updated version of AHRQ comorbidity software for risk adjustment. In contrast, the CSP provided no mechanism for risk adjustment.

These findings also demonstrate the association of complications with increased costs, LOS, and mortality, an association that has been shown previously (Naessens and Huschka, 2004).

limitations and Next Steps

The PPC System has the limitations inherent in any system that uses discharge abstract codes, since the accuracy and completeness of coding can vary across hospitals, and may vary from one diagnosis to another within a hospital (Iezzoni, 1997). Furthermore, any system that relies on diagnosis coding can be subject to systematic coding bias in response to the inherent incentives in the system. Hospitals would have two strong incentives to code actual complications as present on admission: first to minimize their complication rates, and second to increase their patients' SOI at admission. Furthermore, the fact that almost 20 percent of California hospitals had to be eliminated from these analyses because of poor coding of the POA indicator emphasizes that attention would have to be directed to coding compliance. Compliance can be a particular problem for smaller hospitals that may lack the resources to upgrade their coding accuracy. The identification of statistically significant differences in individual PPC rates may also be problematic for smaller hospitals, and it may be necessary to examine only aggregate PPC rates for these hospitals. The applicability of screening algorithms to small hospitals will require more examination.

The PPC method will need to be validated in a variety of ways to ensure that the identification of hospital complications is accurate, and also useful in improving quality of care and patient safety. Validation can take the form of chart review studies to examine the association of various complications with quality problems, and review by expert panels and quality review organizations to examine face validity and content validity.

Acceptability of Complications Methods

If complications screening methods such as PPCs are to be used for performance assessment, they must first address whether ICD-9-CM (Centers for Disease Control and Prevention, 2006) discharge abstract codes can identify in-hospital complications with reasonable accuracy. Several authors have reported low sensitivity, meaning large numbers of unrecorded complications (Best et al., 2002; Geraci et al., 2002, 1997; Romano et al., 2002; Romano, Schembri, and Rainwater, 2002). False-positive rates, on the other hand, have been shown to be lower in several studies, and further reducible if complications were distinguished from comorbidities using chart review (Hannan et al., 1997; Lawthers et al., 2000; Naessens and Huschka, 2004).

Another issue is whether presence of complications correlates with problems in quality of care. Several studies have linked poorer quality of care with in-hospital complications (Geraci et al., 1999; Weingart et al., 2000) but others have identified problems with reproducibility of reviewer judgments (Caplan, Posner, and Cheney, 1991; Goldman, 1992; Hayward, McMahon, and Bernard, 1993; Iezzoni et al., 1999; Rubin et al., 1992), discordance between implicit and explicit assessments of quality, and judgments about whether complications resulted from error and/or negligence (Thomas et al., 2002; Weingart et al., 2002). Despite the uncertain state of current literature, it makes intuitive sense that complications are often related to substandard care. In hospitals where potentially preventable complication rates are significantly higher than average, the expectation of quality problems is higher, and the processes of care at those institutions should be scrutinized more closely.

Complications screening can prompt hospitals to focus indepth reviews either on individual patient records or on processes of care that are potentially deficient. For example, a hospital with a higher than expected rate of aspiration pneumonia or decubitus ulcer among stroke patients might need to review the nursing care on its neurology service. Alternatively, complications screening could be used to create public reports for hospital comparisons, which many quality advocates have endorsed in addition to reports on process measures, mortality rates, LOS, and costs (Berwick, 2002; Steinberg, 2003). Others, perceiving a perverse incentive in paying hospitals more for patients who have complications, have suggested tying reimbursement to complication rates as well as other performance measures (Midwest Business Group on Health, 2002; National Committee for Quality Assurance, 2004).

Although some commentators have raised concerns about the effectiveness and possible negative consequences of such proposals (Mello, Studdert, and Brennan, 2003; Werner and Asch, 2005), and others have been more cautiously optimistic (Marshall, Romano, and Davies, 2004), it is clear that momentum for public performance reporting and pay-for-performance initiatives is increasing. Federal efforts, in addition to the Patient Safety Indicators (Agency for Healthcare Research and Quality, 2005), include a CMS requirement that participating hospitals report selected performance data or face a reduction in payments. CMS has also started several pay-for-performance demonstration projects, and the Medicare Payment Advisory Commission (2005) has recommended a range of pay for performance measures and also endorsed the use of POA indicators. In the Deficit Reduction Act of 2005, Congress required that the POA indicator be reported on all Medicare claims beginning in fiscal year 2008, and further instructed CMS, beginning in fiscal year 2009, to select at least two types of post admission infectious complications that would to no longer be allowed to affect DRG assignment.

Given the level of public and governmental scrutiny, and the considerable resources and effort expended to date on these issues, it is likely that public reporting and financial incentives related to patient safety performance measures in general, and hospital complication rates in particular, will only increase. The effectiveness of these efforts will depend on the integrity of the data and the validity of the methods used in any public reports and performance-based payment systems. Our study suggests that the ability to identify diagnoses present at the time of admission is necessary not only for the proper identification of complications, but also for adequate risk stratification based on patient type and SOI. This ability is critical to the fairness and usefulness of any evaluations of hospital complication rates.

Footnotes

John S. Hughes, M.D., is with the Yale University School of Medicine. Richard F, Averill, Norbert I. Goldfield, M.D., Elizabeth McCullough, and Jean Xiang, are with 3M Health Information Systems. James C. Gay, M.D., is with the Vanderbilt University School of Medicine. John Muldoon is with the National Association of Children's Hospitals and Related Institutions, Inc. The statements expressed in this article are those of the authors and do not necessarily reflect the views of the Yale University School of Medicine, 3M Health Information Systems, the Vanderbilt University School of Medicine, National Association of Children's Hospitals and Related Institutions, or the Centers for Medicare & Medicaid Services (CMS).

Reprint Requests: John S. Hughes, M.D., 3M Health Information Systems, 100 Barnes Road, Wallingford, CT 06492. E-mail: jshughes@mmm.com

References

  1. Agency for Healthcare Research and Quality. AHRQ Quality Indicators—Guide to Patient Safety Indicators. Rockville, MD.: 2005. Version 2.1, Revision 3. [Google Scholar]
  2. Agresti A. Categorical Data Analysis. John Wiley & Sons; New York, NY.: 1990. [Google Scholar]
  3. Averill RF, Goldfield NI, Muldoon J, et al. A Closer Look at All-Patient Refined DRGs. Journal of AHIMA. 2002 Jan;73(1):46–50. [PubMed] [Google Scholar]
  4. Berwick DM. Public Performance Reports and the Will for Change. JAMA. 2002 Sep 25;288(12):1523–1524. doi: 10.1001/jama.288.12.1523. [DOI] [PubMed] [Google Scholar]
  5. Best WR, Khuri SF, Phelan M, et al. Identifying Patient Preoperative Risk Factors and Postoperative Adverse Events in Administrative Databases: Results From the Department of Veterans Affairs National Surgical Quality Improvement Program. Journal of the American College of Surgeons. 2002 Mar;194(3):257–266. doi: 10.1016/s1072-7515(01)01183-8. [DOI] [PubMed] [Google Scholar]
  6. Brailer DJ, Kroch E, Pauly MV, et al. Comorbidity-Adjusted Complication Risk: A New Outcome Quality Measure. Medical Care. 1996 May;34(5):490–505. doi: 10.1097/00005650-199605000-00010. [DOI] [PubMed] [Google Scholar]
  7. Caplan RA, Posner KL, Cheney FW. Effect of Outcome on Physician Judgments of Appropriateness of Care. JAMA. 1991 Apr 17;265(15):1957–1960. [PubMed] [Google Scholar]
  8. Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Internet address: http://www.cdc.gov/nchs/about/other-act/icd9/abticd9.htm. (Accessed 2006.)
  9. Daley J, Henderson WG, Khuri SF. Risk-Adjusted Surgical Outcomes. Annual Review of Medicine. 2001 Feb;52:275–287. doi: 10.1146/annurev.med.52.1.275. [DOI] [PubMed] [Google Scholar]
  10. DesHarnais SI, McMahon LF, Jr, Wroblewski RT, et al. Measuring Hospital Performance. The Development and Validation of Risk-Adjusted Indexes of Mortality, Readmissions, and Complications. Medical Care. 1990 Dec;28(12):1127–1141. [PubMed] [Google Scholar]
  11. Geraci JM. The Demise of Comparative Provider Complication Rates Derived From ICD-9-CM Code Diagnoses. Medical Care. 2002 Oct;40(10):847–850. doi: 10.1097/00005650-200210000-00001. [DOI] [PubMed] [Google Scholar]
  12. Geraci JM, Ashton CM, Kuykendall DH, et al. The Association of Quality of Care and Occurrence of In-Hospital, Treatment-Related Complications. Medical Care. 1999 Feb;37(2):140–148. doi: 10.1097/00005650-199902000-00004. [DOI] [PubMed] [Google Scholar]
  13. Geraci JM, Ashton CM, Kuykendall DH, et al. International Classification of Diseases, Ninth Revision, Clinical Modification Codes in Discharge Abstracts Are Poor Measures of Complication Occurrence in Medical Inpatients. Medical Care. 1997 Jun;35(6):589–602. doi: 10.1097/00005650-199706000-00005. [DOI] [PubMed] [Google Scholar]
  14. Goldman RL. The Reliability of Peer Assessments of Quality of Care. JAMA. 1992 Feb 19;267(7):958–960. [PubMed] [Google Scholar]
  15. Hannan EL, Racz MJ, Jollis JG, et al. Using Medicare Claims Data to Assess Provider Quality for CABG Surgery: Does It Work Well Enough? Health Services Research. 1997 Feb;31(6):659–678. [PMC free article] [PubMed] [Google Scholar]
  16. Hayward RA, McMahon LF, Jr, Bernard AM. Evaluating the Care of General Medicine Inpatients: How Good Is Implicit Review? Annals of Internal Medicine. 1993 Apr 1;118(7):550–556. doi: 10.7326/0003-4819-118-7-199304010-00010. [DOI] [PubMed] [Google Scholar]
  17. Iezzoni LI. Assessing Quality Using Administrative Data. Annals of Internal Medicine. 1997 Oct 15;127(8 Pt. 2):666–674. doi: 10.7326/0003-4819-127-8_part_2-199710151-00048. [DOI] [PubMed] [Google Scholar]
  18. Iezzoni LI, Daley J, Heeren T, et al. Identifying Complications of Care Using Administrative Data. Medical Care. 1994 Jul;32(7):700–715. doi: 10.1097/00005650-199407000-00004. [DOI] [PubMed] [Google Scholar]
  19. Iezzoni LI, Davis RB, Palmer RH, et al. Does the Complications Screening Program Flag Cases With Process of Care Problems? Using Explicit Criteria to Judge Processes. International Journal for Quality in Health Care. 1999 Apr;11(2):107–118. doi: 10.1093/intqhc/11.2.107. [DOI] [PubMed] [Google Scholar]
  20. Iezzoni LI, Foley SM, Heeren T, et al. A Method for Screening the Quality of Hospital Care Using Administrative Data: Preliminary Validation Results. Quality Review Bulletin. 1992 Nov;18(11):361–371. doi: 10.1016/s0097-5990(16)30557-7. [DOI] [PubMed] [Google Scholar]
  21. Kohn LT, Corrigan JM, Donaldson MS, editors. Institute of Medicine. To Err Is Human: Building a Safer Health System. National Academy Press; Washington, DC.: 2000. [PubMed] [Google Scholar]
  22. Lawthers AG, McCarthy EP, Davis RB, et al. Identification of In-hospital Complications from Claims Data. Is It Valid? Medical Care. 2000 Aug;38(8):785–795. doi: 10.1097/00005650-200008000-00003. [DOI] [PubMed] [Google Scholar]
  23. Marshall MN, Romano PS, Davies HT. How Do We Maximize the Impact of the Public Reporting of Quality of Care? International Journal for Quality in Health Care. 2004 Apr;16(Suppl. 1):157–163. doi: 10.1093/intqhc/mzh013. [DOI] [PubMed] [Google Scholar]
  24. Medicare Payment Advisory Commission. Medicare Payment Policy. Washington, DC.: Mar, 2005. Report to the Congress. [Google Scholar]
  25. Mello MM, Studdert DM, Brennan TA. The Leapfrog Standards: Ready to Jump From Marketplace to Courtroom? Health Affairs. 2003 Mar-Apr;22(2):46–59. doi: 10.1377/hlthaff.22.2.46. [DOI] [PubMed] [Google Scholar]
  26. Midwest Business Group on Health. Reducing the Costs of Poor Quality Health Care Through Responsible Purchasing Leadership. Chicago, IL.: Jun, 2002. [Google Scholar]
  27. Naessens JM, Huschka TR. Distinguishing Hospital Complications of Care From Pre-Existing Conditions. International Journal for Quality in Health Care. 2004 Apr;16(Suppl. 1):127–135. doi: 10.1093/intqhc/mzh012. [DOI] [PubMed] [Google Scholar]
  28. National Committee for Quality Assurance. The State of Health Care Quality 2004. Rockville, MD.: 2004. [Google Scholar]
  29. Romano PS, Chan BK, Schembri ME, et al. Can Administrative Data Be Used to Compare Postoperative Complication Rates Across Hospitals? Medical Care. 2002a Oct;40(10):856–867. doi: 10.1097/00005650-200210000-00004. [DOI] [PubMed] [Google Scholar]
  30. Romano PS, Geppert JJ, Davies S, et al. A National Profile of Patient Safety in U.S. Hospitals. Health Affairs. 2003 Mar-Apr;22(2):154–166. doi: 10.1377/hlthaff.22.2.154. [DOI] [PubMed] [Google Scholar]
  31. Romano PS, Schembri ME, Rainwater JA. Can Administrative Data Be Used to Ascertain Clinically Significant Postoperative Complications? American Journal of Medical Quality. 2002b Jul-Aug;17(4):145–154. doi: 10.1177/106286060201700404. [DOI] [PubMed] [Google Scholar]
  32. Rosen AK, Ash AS, McNiff KJ, et al. The Importance of Severity of Illness Adjustment in Predicting Adverse Outcomes in the Medicare Population. Journal of Clinical Epidemiology. 1995 May;48(5):631–643. doi: 10.1016/0895-4356(94)00165-m. [DOI] [PubMed] [Google Scholar]
  33. Rothschild JM, Bates DW, Leape LL. Preventable Medical Injuries in Older Patients. Archives of Internal Medicine. 2000 Oct 9;160(18):2717–2728. doi: 10.1001/archinte.160.18.2717. [DOI] [PubMed] [Google Scholar]
  34. Rubin HR, Rogers WH, Kahn KL, et al. Watching the Doctor-Watchers. How Well Do Peer Review Organization Methods Detect Hospital Care Quality Problems? JAMA. 1992 May 6;267(17):2349–2354. doi: 10.1001/jama.267.17.2349. [DOI] [PubMed] [Google Scholar]
  35. Steinberg EP. Improving the Quality of Care—Can We Practice What We Preach? New England Journal of Medicine. 2003 Jun 26;348(26):2681–2683. doi: 10.1056/NEJMe030085. [DOI] [PubMed] [Google Scholar]
  36. Thomas EJ, Brennan TA. Incidence and Types of Preventable Adverse Events in Elderly Patients: Population Based Review of Medical Records. BMJ. 2000 Mar 18;320(7237):741–744. doi: 10.1136/bmj.320.7237.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Thomas EJ, Lipsitz SR, Studdert DM, et al. The Reliability of Medical Record Review for Estimating Adverse Event Rates. Annals of Internal Medicine. 2002 Jun 4;136(11):812–816. doi: 10.7326/0003-4819-136-11-200206040-00009. [DOI] [PubMed] [Google Scholar]
  38. Weingart SN, Davis RB, Palmer RH, et al. Discrepancies Between Explicit and Implicit Review: Physician and Nurse Assessments of Complications and Quality. Health Services Research. 2002 Apr;37(2):483–498. doi: 10.1111/1475-6773.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Weingart SN, Iezzoni LI, Davis RB, et al. Use of Administrative Data to Find Substandard Care: Validation of the Complications Screening Program. Medical Care. 2000 Aug;38:796–806. doi: 10.1097/00005650-200008000-00004. [DOI] [PubMed] [Google Scholar]
  40. Werner RM, Asch DA. The Unintended Consequences of Publicly Reporting Quality Information. JAMA. 2005 Mar 9;293(10):1239–1244. doi: 10.1001/jama.293.10.1239. [DOI] [PubMed] [Google Scholar]

Articles from Health Care Financing Review are provided here courtesy of Centers for Medicare and Medicaid Services

RESOURCES